Stem Cell Therapeutic Outcomes Database

ICR 202309-0915-005

OMB: 0915-0310

Federal Form Document

ICR Details
0915-0310 202309-0915-005
Received in OIRA 202302-0915-002
HHS/HSA 21065
Stem Cell Therapeutic Outcomes Database
No material or nonsubstantive change to a currently approved collection   No
Regular 09/20/2023
  Requested Previously Approved
08/31/2025 08/31/2025
75,101 75,101
75,101 75,101
0 0

The Stem Cell Therapeutic Outcomes Database was established under contract by HRSA to establish and maintain information related to patients who have received stem cell therapeutic products using a standardized, electronic format. Data is collected from transplant centers by the Center for International Blood and Marrow Transplant Research and is used for ongoing analysis of transplant outcomes. HRSA uses the information to carry out its statutory responsibilities. Information is needed to monitor the clinical status of transplantation and to provide the Secretary of HHS with an annual report of transplant center-specific survival data.

PL: Pub.L. 109 - 129 0 Name of Law: The Stem Cell Therapeutic and Research Reauthorization Act of 2010
   US Code: 42 USC 24K, section 379 Name of Law: TRANSPLANT Act of 2021
   PL: Pub.L. 111 - 148 0 Name of Law: TRANSPLANT Act of 2021’’
  
None

Not associated with rulemaking

  87 FR 15439 03/18/2022
87 FR 34692 06/07/2022
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 75,101 75,101 0 0 0 0
Annual Time Burden (Hours) 75,101 75,101 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
This is a revised collection of information with an estimated reduction to the overall hour burden inventory to 75,106 due to improvements in burden estimation. As noted in Table 1, the total number of responses is less than previous calculations because of improvements in estimation. The number of responses in any given year is a function of three values: the number of transplants in the year of interest, the number of transplants in previous years, and expected patient survival between the time of transplant and any follow-up activity. Previous estimates assumed all years had the same number of transplants. This improved estimate includes accurate transplant counts from prior years, which are often less that the year of interest.

$4,730,240
No
    No
    No
No
No
No
Yes
Laura Cooper 301 443-2126 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/20/2023


© 2024 OMB.report | Privacy Policy